Literature DB >> 16013021

Renal failure and hypertension in Alagille syndrome with a novel JAG1 mutation.

Sigrid Harendza1, Christian A Hübner, Christiane Gläser, Martin Burdelski, Friedrich Thaiss, Ingo Hansmann, Andreas Gal, Rolf A K Stahl.   

Abstract

Renal failure and hypertension in Alagille syndrome with a novel JAG1 mutation: Alagille syndrome is an autosomal dominant disorder involving liver, heart, eyes, face, skeleton, and other organs. Various renal abnormalities have also been associated with Alagille syndrome, whereas renal vascular hypertension combined with renal insufficiency has been reported in several cases. We describe a patient with a novel frameshift mutation (c.1880_1881insA) in the JAG1 gene who presented with chronic renal failure and hypertension but without evidence of renal vascular or aortic stenosis. The patient's chronic renal failure had persisted for several years. His high blood pressure seemed to be due to renal parenchymal changes and was treated with ACE-inhibitors without worsening his renal function. This novel JAG1 mutation revealed great variability of the phenotype. The patient's daughter suffered from severe paucity of intrahepatic bile ducts and received a liver transplant at the age of two years. These findings are discussed including a review of the literature.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16013021

Source DB:  PubMed          Journal:  J Nephrol        ISSN: 1121-8428            Impact factor:   3.902


  9 in total

Review 1.  From ureteric bud to the first glomeruli: genes, mediators, kidney alterations.

Authors:  Vassilios Fanos; Cristina Loddo; Melania Puddu; Clara Gerosa; Daniela Fanni; Giovanni Ottonello; Gavino Faa
Journal:  Int Urol Nephrol       Date:  2014-09-09       Impact factor: 2.370

2.  NOTCH2 mutations in Alagille syndrome.

Authors:  Binita Maya Kamath; Robert C Bauer; Kathleen M Loomes; Grace Chao; Jennifer Gerfen; Anne Hutchinson; Winita Hardikar; Gideon Hirschfield; Paloma Jara; Ian D Krantz; Pablo Lapunzina; Laura Leonard; Simon Ling; Vicky Lee Ng; Phuc Le Hoang; David A Piccoli; Nancy Bettina Spinner
Journal:  J Med Genet       Date:  2011-12-29       Impact factor: 6.318

3.  NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway.

Authors:  Ryan McDaniell; Daniel M Warthen; Pedro A Sanchez-Lara; Athma Pai; Ian D Krantz; David A Piccoli; Nancy B Spinner
Journal:  Am J Hum Genet       Date:  2006-05-10       Impact factor: 11.025

4.  Renal anomalies in Alagille syndrome: a disease-defining feature.

Authors:  Binita M Kamath; Gisele Podkameni; Anne L Hutchinson; Laura D Leonard; Jennifer Gerfen; Ian D Krantz; David A Piccoli; Nancy B Spinner; Kathleen M Loomes; Kevin Meyers
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

5.  Glomerular basement membrane lipidosis in Alagille syndrome.

Authors:  Jessica Davis; Ryan Griffiths; Kay Larkin; David Rozansky; Megan Troxell
Journal:  Pediatr Nephrol       Date:  2010-01-21       Impact factor: 3.714

Review 6.  Renal involvement and the role of Notch signalling in Alagille syndrome.

Authors:  Binita M Kamath; Nancy B Spinner; Norman D Rosenblum
Journal:  Nat Rev Nephrol       Date:  2013-06-11       Impact factor: 28.314

7.  Adult-onset renal failure in a family with Alagille syndrome with proteinuria and a novel JAG1 mutation.

Authors:  Norifumi Hayashi; Hiroshi Okuyama; Yuki Matsui; Hideki Yamaya; Eriko Kinoshita; Hiroshi Minato; Yo Niida; Hitoshi Yokoyama
Journal:  Clin Kidney J       Date:  2013-03-29

8.  An Adult Patient with Alagille Syndrome Showing Mainly Renal Failure and Vascular Abnormality without Liver Manifestation.

Authors:  Homare Shimohata; Kazuo Imagawa; Marina Yamashita; Kentaro Ohgi; Hiroshi Maruyama; Mamiko Takayasu; Kouichi Hirayama; Masaki Kobayashi
Journal:  Intern Med       Date:  2020-07-28       Impact factor: 1.271

9.  Hypertension and Biliary Ductopenia in a Patient with Duplication of Exon 6 of the JAG1 Gene.

Authors:  J Uberos; L Moreno; A Muñoz-Hoyos
Journal:  Clin Med Insights Pediatr       Date:  2012-07-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.